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INTRODUCTION
Physical inactivity is the fourth leading cause of global mortality (World Health Organisation, 2009 ) responsible for 6-10% of the major non-communicable diseases of coronary heart disease, type 2 diabetes, and breast and colon cancer (Lee et al., 2012) . Whilst sport, running and vigorous gym based exercise are often seen as counter measures, walking offers a natural, widely accepted, low cost, low injury risk (Hootman et al., 2001) , environmentally friendly approach to physical activity which can be incorporated into activities of daily living and/or undertaken recreationally. Walking is also likely to be more accessible and suitable to a considerable portion of the higher-risk population who may be obese, sedentary, at high risk of cardiovascular disease and for whom strenuous forms of exercise may be unsuitable. Walking at a self-selected pace is moderate intensity for most adults (Ainsworth et al., 2000; Murtagh et al., 2002) . Indeed it is estimated that walking at 3mph would be vigorous intensity for approximately 20% of the population (Kelly et al., 2011) . Systematic reviews have indicated that inactive people can be encouraged to walk more by tailored interventions (Ogilvie et al., 2007) Whilst it is unsurprising that walking has become a cornerstone of physical activity promotion strategies, a challenge faced by healthcare professionals and patients is knowing the effects of walking on health, especially as many published walking interventions employ relatively small samples and findings are often inconsistent between studies. Conversely, the use of meta-analysis increases the precision and accuracy of the estimates of the effects of walking, quantifies the inconsistency between studies and enhances generalizability to a larger population. We previously reported a meta-analysis of walking interventions published up to 2004, that included aerobic fitness, blood pressure, and body composition (Murphy et al., 2007) . Since then there has been an increase in the number of published interventions examining the effects of walking on risk factors for cardiovascular disease. In addition, an increased range of outcome measures have been included in these studies, such as blood lipids and several measures of adiposity. While there is now greater evidence of the concomitant dangers of these factors to public health (Physical Activity Guidelines Advisory Committee, 2008) a recent comprehensive synthesis of evidence from randomised control trials on the effect of walking on health is lacking. This updated meta-analysis therefore expands our understanding of the treatment-effect relationship between walking and health. The objective of this study was to assess the effect of walking interventions on risk factors for cardiovascular disease in previously inactive adults. This updates our previous review and provides healthcare professionals with a synthesis of the effects accruing when inactive adults undertake a walking programme.
METHODS
We followed the PRISMA statement (preferred reporting items for systemic reviews and meta-analyses) in conducting and reporting the meta-analysis (Moher et al., 2009) . A review protocol has not been published separately.
Data sources and searches
The following electronic databases were searched: PubMed, Web of Science, ScienceDirect 
Study selection
The study selection process is summarised in figure 1. Initial eligibility assessment was performed by one author by reviewing the title and abstracts. The full text versions of 48 articles were then reviewed independently by two authors. Disagreements between reviewers were resolved by consensus by reassessing each of the eligibility criteria for the study.
The following eligibility criteria were used: randomised, controlled trials studying the effect of walking on one or more cardiovascular risk factors; trials with at least one group who completed walking as the only intervention; training for a minimum of four weeks; noexercise control group; participants aged 18 years or older who were reported as being apparently sedentary but otherwise healthy at baseline; selected cardiovascular disease risk factors assessed pre-and post-intervention (or change from pre-to post-intervention reported); English language articles published in peer-reviewed journals between January 1971 and June 2012.
Data extraction and quality assessment
We used a modified version of the data extraction sheet developed for the previous metaanalysis. Two individuals extracted the data from included studies and a second author checked the extracted data. Disagreements were resolved by consensus. Two of the selected studies were suspected to be reports from the same participants -this was confirmed by contacting the authors. The authors of eight articles were contacted for further information (Aldred and Rohalu, 2011; Baker et al., 2008; Osei-Tutu and Campagna, 2005; Stensel et al., 1994; Stensel et al., 1993; Tully et al., 2005; Tully et al., 2007; Woolf-May et al., 2011) . All responded and provided numerical data (Aldred and Rohalu, 2011; Osei-Tutu and Campagna, 2005; Tully et al., 2005; Tully et al., 2007) or clarifications regarding the study protocol (Aldred and Rohalu, 2011; Baker et al., 2008; Stensel et al., 1994; Stensel et al., 1993 ) that were not detailed in the published paper. Previously unpublished numerical data was obtained from the original researchers of three articles (Osei-Tutu and Campagna, 2005; Tully et al., 2005; Tully et al., 2007) .
The previous meta-analysis extracted data on: 1) Participant characteristics (age, sex, number of men and women)
2) Intervention characteristics (duration, frequency, intensity of walking, duration of the intervention)
3) Outcome measures (aerobic fitness, body weight, body fat percentage, body mass index, systolic blood pressure and diastolic blood pressure).
4) Study design
In addition to the above items, the following outcome measures were extracted from all included studies: total cholesterol, HDL cholesterol, LDL cholesterol, waist circumference, waist-to-hip ratio.
The Cochrane Collaboration "risk of bias" assessment tool was employed. Two authors, with adequate reliability, evaluated studies for sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting and other potential threats to validity .
Data synthesis and statistical analysis
Treatment effect was calculated by subtracting pre-intervention mean from the postintervention mean (postpre) for both exercise (delta 1) and control (delta 2) groups.
Treatment effect was then obtained as delta 1delta 2 for each study. Six studies reported data on standard deviation of change between pre-and post-intervention measurements Murphy and Hardman, 1998; Murphy et al., 2006; Tully et al., 2005; Tully et al., 2007; Woolf-May et al., 2011) . If not reported, standard deviation of the individual delta values were calculated using pre-and post-standard deviations and the mean pre/post correlation from studies which reported sufficient detail to calculate correlation . To assess the effect of this assumption, sensitivity analyses were performed using minimum and maximum available pre-post correlations. In trials that had more than two intervention arms the description of the interventions were checked to ensure they only varied in the level of exercise undertaken and if so all intervention arms were collapsed into a single treatment arm .
Seven studies reported weight and height as outcomes but did not report body mass index Duncan et al., 1991; Hinkleman and Nieman, 1993; Moreau et al., 2001; Osei-Tutu and Campagna, 2005; Santiago et al., 1995; Woolf-May et al., 2011) . For these studies, an approximation for the mean and standard deviation of body mass index was derived using formulae for the product and ratio of random variables (Stuart and Ord, 1987) .
A sensitivity analysis was performed on the body mass index outcome by including and excluding these approximated data. Similarly, waist-to-hip ratio was approximated using separately reported waist and hip circumference data from the three studies Murtagh et al., 2005; Serwe et al., 2011) .
Pooled results were reported as weighted mean treatment effects and 95% confidence intervals using a random effects model (DerSimonian and Laird method(DerSimonian and Laird, 1986)). Statistical heterogeneity was evaluated using the I 2 statistic. Publication bias was appraised by visual inspection of the funnel plots of treatment effect against standard error (to identify asymmetry, which can indicate evidence of non-publication of small trials with negative results) and also by Egger"s test (Egger et al., 1997) . To investigate possible sources of heterogeneity across studies we performed a meta-regression analysis to investigate the effects of the following study specific characteristics on treatment effect: mean age of participants, mean pre-intervention weight, gender (proportion of male participants) and duration of intervention. A p-value <0.05 was considered statistically significant. All analyses were conducted using Stata, Version 12 (StataCorp, College Station, TX).
RESULTS

Study selection
A total of 210 articles were identified by electronic searches and 16 articles from handsearching. Thirty one duplicates were then excluded. After reviewing the title and abstract of the 195 articles identified, 150 were excluded as they did not meet the inclusion criteria. The full text versions of 45 articles were then reviewed. Fifteen studies were deemed eligible for inclusion in the study and combined with studies reported in our previous meta-analysis (Murphy et al., 2007) (n=17) . Therefore in total 32 articles are included in this systemic review and updated meta-analysis. See figure 1 for further information. Two articles reported different outcomes measures from the same subjects in a larger study Stensel et al., 1993) and so the results from these two articles were combined to represent one study in the meta-analysis.
Study characteristics
All studies selected for this review are randomised controlled trials published in English.
Subject and intervention characteristics are summarised in Aldred and Rohalu, 2011; Anderson et al., 2006; Asikainen et al., 2002a; Asikainen et al., 2002b; Duncan et al., 1991; Hamdorf and Penhall, 1999; Hinkleman and Nieman, 1993; Jette et al., 1988; Murphy and Hardman, 1998; Murtagh et al., 2005; Osei-Tutu and Campagna, 2005; Probart et al., 1991; Ready et al., 1995; Ready et al., 1996; Santiago et al., 1995; Stensel et al., 1994; Stensel et al., 1993; Woolf-May et al., 1999) . Three studies incorporated a vigorous intensity (Ewing Garber et al., 2011) walking group Duncan et al., 1991; Serwe et al., 2011) and three studies included a light intensity group Duncan et al., 1991; Murphy et al., 2006) . Additionally, five studies reported that walking was self-paced Butcher et al., 2008; Moreau et al., 2001 ; Morgan Simons and Andel, 2006) and four noted that walking intensity was at a brisk pace Tully et al., 2005; Tully et al., 2007) . It was a criterion for inclusion that studies included a no-exercise control group. All authors were contacted to confirm the data extracted in the study characteristics table and responses were received from the authors of 21 articles. Abbreviations: Accum = accumulated, AA=African American, Con = control group, f = female, HRmax = maximum heart rate, HRR = heart rate reserve, IW = intermediate walkers, LW = long walkers, m = males, mins = minutes, mod = moderate, SW = short walkers, VO 2max = maximal oxygen consumption, VO 2peak = peak oxygen consumption, W = White, walk = walk group, Wmax = maximal performance Databases were searched for articles published between Jan 1971 and June 2012. Note: Subject numbers are those included in the analysis unless otherwise stated. 
A C C E P T E D M A N U S C R I P T
Aerobic fitness
Observed VO 2max , predicted VO 2max and VO 2peak were utilised as the outcome measure of aerobic fitness. Twelve studies reported VO 2max (Aldred and Rohalu, 2011; Asikainen et al., 2002a; Asikainen et al., 2002b; Braith et al., 1994; Duncan et al., 1991; Hinkleman and Nieman, 1993; Jette et al., 1988; Murphy and Hardman, 1998; Osei-Tutu and Campagna, 2005; Probart et al., 1991; Ready et al., 1995; Santiago et al., 1995) , four reported predicted VO 2max Butcher et al., 2008; Woolf-May et al., 1999;  Woolf-May et al., 2011) and two reported VO 2peak Ready et al., 1996) .
There was a statistically significant improvement in VO 2max of 3.04 mL/kg/min (95% CI 2.48 to 3.60) in the participants who followed the walking intervention. There was, however, evidence of significant heterogeneity between the results (I 2 =71%, p<0.001).
Anthropometric measures
Sixteen trials examined the effect of walking on body mass index (Aldred and Rohalu, 2011; Anderson et al., 2006; Asikainen et al., 2002a; Asikainen et al., 2002b; Baker et al., 2008; Bell et al., 2010; Butcher et al., 2008; Murphy et al., 2006; Probart et al., 1991; Ready et al., 1995; Ready et al., 1996; Serwe et al., 2011; Stensel et al., 1994; Tully et al., 2005; Tully et al., 2007) and a further seven trials reported height and weight, allowing body mass index to be approximated Duncan et al., 1991; Hinkleman and Nieman, 1993; Moreau et al., 2001; Osei-Tutu and Campagna, 2005; Santiago et al., 1995; Woolf-May et al., 2011) . The pooled effect of the walking intervention was a statistically significant reduction in body mass index of 0.53 kg/m 2 (95% CI -0.72 to -0.35). A sensitivity analysis considering only those studies which reported body mass index directly as an outcome found a similar estimate of effect (0.49 kg/m 2 reduction (95% CI -0.70 to -0.27)). There was substantial heterogeneity between the studies (I 2 =70%, p<0.001). The funnel plot showed some asymmetry indicating that smaller studies which found an increase in body mass index in the intervention group appeared to be absent (Egger's test, p=0.005) .
Eleven studies measured waist circumference Baker et al., 2008; Bell et al., 2010; Murphy and Hardman, 1998; Murphy et al., 2006; Murtagh et al., 2005; Serwe et al., 2011; Tully et al., 2005; Tully et al., 2007; Woolf-May et al., 2011) .
Overall a significant reduction of 1.51 cm (95% CI -2.34 to -0.68) was found when the studies were pooled. The funnel plot showed some asymmetry indicating an absence of smaller studies (Egger"s test, p=0 .02).
A C C E P T E D M A N U S C R I P T
reduction in body fat of 1.22% (95% CI -1.70 to -0.73). There was substantial heterogeneity between studies (I 2 =68%, p<0.001).
Blood pressure
The weighted mean treatment effect of the sixteen trials which measured systolic blood pressure Bell et al., 2010; Braith et al., 1994; Butcher et al., 2008; Duncan et al., 1991; Hamdorf and Penhall, 1999; Murphy and Hardman, 1998; Murphy et al., 2006; Murtagh et al., 2005; Ready et al., 1996; Serwe et al., 2011; Simons and Andel, 2006; Tully et al., 2005; Tully et al., 2007; Woolf-May et al., 2011) was -3.58 mmHg (95% CI -5.19 to -1.97) indicating a reduction in systolic blood pressure in those who followed a program of walking. Diastolic blood pressure was also reported by sixteen studies Bell et al., 2010; Braith et al., 1994; Butcher et al., 2008; Duncan et al., 1991; Hamdorf and Penhall, 1999; Moreau et al., 2001; Murphy et al., 2006; Murtagh et al., 2005; Ready et al., 1996; Serwe et al., 2011; Simons and Andel, 2006; Tully et al., 2005; Tully et al., 2007; Woolf-May et al., 2011) and the weighted mean treatment effect of the walking intervention was a significant reduction of 1.54 mmHg (95% CI -2.83 to -0.26).
Lipids
Data on the effect of walking on total cholesterol were available from sixteen studies Bell et al., 2010; Butcher et al., 2008; Duncan et al., 1991; Hinkleman and Nieman, 1993; Morgan et al., 2010; Murphy et al., 2006; Murtagh et al., 2005; Ready et al., 1995; Ready et al., 1996; Santiago et al., 1995; Stensel et al., 1993; Tully et al., 2005; Tully et al., 2007; Woolf-May et al., 1999; Woolf-May et al., 2011) , HDL cholesterol from fifteen studies Bell et al., 2010; Butcher et al., 2008; Duncan et al., 1991; Morgan et al., 2010; Murphy et al., 2006; Murtagh et al., 2005; Ready et al., 1995; Santiago et al., 1995; Stensel et al., 1993; Tully et al., 2005; Tully et al., 2007; Woolf-May et al., 1999; Woolf-May et al., 2011) , and LDL cholesterol from fourteen studies Butcher et al., 2008; Duncan et al., 1991; Hinkleman and Nieman, 1993; Murphy et al., 2006; Murtagh et al., 2005; Ready et al., 1995; Ready et al., 1996; Santiago et al., 1995; Stensel et al., 1993; Tully et al., 2005; Tully et al., 2007; Woolf-May et al., 1999; Woolf-May et al., 2011) . None of the pooled treatment effects for blood lipid outcomes were statistically significant. There was no evidence of publication bias, nor was any betweenstudy heterogeneity found.
A C C E P T E D M A N U S C R I P T
For all outcomes, sensitivity analyses to assess the impact of the correlation coefficient used for imputing standard deviation of change score did not result in any variation in significance of the pooled treatment effect. Similarly, meta-regression analyses were conducted to assess whether heterogeneity could be explained by age, baseline weight, gender or duration of intervention. With the exception of body weight, where a gender effect was found to explain some of the heterogeneity, the majority of the slope parameters were found to be nonsignificant (see appendix 12).
Risk of bias of individual studies
Details of the risk-of-bias assessment appear in Table 3 . Only two studies were judged to be at low risk of bias. Many studies did not provide sufficient information to make firm judgements about bias. Databases were searched for articles published between Jan 1971 and June 2012.
A C C E P T E D M A N U S C R I P T
DISCUSSION
This updated systematic review and meta-analysis suggests that walking programmes improve several markers of cardiovascular risk, including aerobic capacity, systolic and diastolic blood pressure, and adiposity (waist circumference, body mass, percentage body fat and body mass index) in previously inactive but apparently healthy adults. However there was no evidence of changes in total cholesterol, HDL cholesterol, LDL cholesterol or waistto-hip ratio. In this updated meta-analysis we analysed five additional outcome variables not included in our earlier publication (Murphy et al., 2007) , namely total cholesterol, HDL cholesterol, LDL cholesterol, waist-to-hip ratio and waist circumference, and identified an additional 15 relevant studies. Overall, this body of evidence supports the role of walking as a central feature of individual and population health promoting strategies to ameliorate the escalating global burden of cardiovascular disease.
Aerobic fitness
Aerobic fitness is an independent risk factor for cardiovascular disease and a stronger risk factor than physical activity alone Blair and Jackson, 2001) . VO 2max , considered the "gold standard" for the assessment of aerobic fitness (Murphy et al., 2007) , was measured or predicted in 18 of the studies included and showed a significant weighted mean treatment effect (TE) of 3.04 ml/kg/min. Consequences of improvement in aerobic capacity include greater ease of performance of everyday physical activities and improved quality of life for the individual (Murphy et al., 2007) . From a population perspective an improvement of this magnitude (approx 10%) is likely to result in a 15% reduction in mortality (Dunn et al., 1999) , irrespective of the baseline fitness level (Blair et al., 1995) .
Healthcare professionals should be mindful however that walking needs to be of at least moderate intensity (64-76% HR max) (American College of Sports Medicine, 2010) in order to improve aerobic fitness . Evidence has demonstrated that even greater fitness improvements can be attained from walking at vigorous intensity Nicklas et al., 2009 ).
Blood pressure
Hypertension is a major risk factor for cardiovascular disease (Egan et al., 2010) . A significant reduction in systolic blood pressure of 3.58mm Hg and in diastolic blood pressure of 1.54 mm Hg was observed in this meta-analysis. This weighted mean treatment effect is similar to findings of an earlier meta-analysis focussing on walking and resting blood
pressure (Kelley et al., 2001) . A previous prospective study reported that a 2mm Hg reduction in systolic blood pressure would result in 10% lower stroke mortality and 7% lower mortality from ischaemic heart disease or other vascular causes in middle age (Prospective Studies Collaboration, 2002) , thus highlighting the clinical significance of even small changes in resting blood pressure. Given that hypertension has wide-scale population prevalence, affecting approximately 19 -32% of men and women in UK (Maryon-Davis, 2005 ) and 29% of US adults (Egan et al., 2010) , policy makers should consider the central role walking could play in population blood pressure control strategies.
Lipids
Elevated total cholesterol levels have been associated with coronary heart disease mortality (Menotti and Lanti, 2003) and also found to be independently predictive of ischemic heart disease (Yarnell et al., 2001 ). In the current review 16 studies reported total cholesterol and a non-significant weighted mean treatment effect of -0.12 mmol/L was found. The weighted mean treatment effect for HDL cholesterol of 0.01 mmol/L did not reach statistical significance, which may be linked to the optimal mean pre-intervention values of these LDL cholesterol was reported in 14 studies in this meta-analysis, however the mean TE of -0.05 mmol/L was not significant. Some authors have suggested that changes in apolipoprotiens A or B may reduce cardiovascular risk by increasing the LDL-C particle size without changing LDL levels and therefore monitoring apolipoproteins rather than just the cholesterol of lipoproteins might be a more sensitive measure of exercise induced changes in lipoprotein function (Holme et al., 2007) .
Anthropometric measures
Obesity is a major influence on the development of cardiovascular diseases (Kumanyika et al., 2008) . Several measures of overweight and obesity were utilised in the studies included in (Dobbelsteyn et al., 2001) , also demonstrated a significant TE of -1.51cm. Although the treatment effect observed in waist circumference may be small, a previous meta-regression analysis of prospective studies demonstrated that a 1cm increase in waist circumference was associated with a 2% increase in the relative risk of a cardiovascular disease event (de Koning et al., 2007) . So even small improvements in waist circumference resulting from walking interventions may have substantial public health gains.
Limitations
While this meta-analysis provides useful updated information for healthcare providers and policy-makers, the results should be interpreted with the following limitations in mind. First, this meta-analysis pooled data from several studies in order to calculate mean weighted treatment effects. However the walking intervention employed, in terms of dose of exercise and support provided, is not the same across studies. Second, risk of bias, assessed using the Cochrane Collaboration assessment tool , revealed that many studies did not provide sufficient information to make firm judgements about bias. Third, observed changes in cardiovascular risk factors may be mediated by a change in another risk factor.
For example change in VO 2max measured per unit of body mass may be affected by change in body mass therefore the impact of the intervention on a single outcome measure is difficult to isolate. Fourth, the search strategy was restricted to English-language publications. Fifth, several studies did not fully report outcomes of interest and not all authors who were contacted for further information provided missing data. Additionally, for many of the studies standard deviation of change from baseline was not reported and these data were imputed using the mean correlation coefficient from the available data. Sensitivity analyses were performed using a range of correlation coefficients which did not show any changes to the pooled effect sizes. Sixth, publication bias was evident for some outcomes including body mass index, weight and waist circumference. Asymmetrical funnel plots suggested that there was an absence of small studies with negative findings (favouring the control group). Finally
A C C E P T E D M A N U S C R I P T
ACCEPTED MANUSCRIPT
21 the majority of subjects in the studies were middle-aged and female. While this may reflects the appeal that this form of physical activity has for women (Murphy et al., 2007) , the applicability of these findings to a male populations may therefore be limited.
Conclusions
Our findings confirm the important role that regular walking can play in the prevention of cardiovascular disease. The meta-analysis revealed positive changes for multiple cardiovascular disease risk factors, including aerobic fitness, systolic and diastolic blood pressure, and several measures of adiposity in previously inactive adults who walked as part of a randomised controlled trial. Clinicians and health-care providers can prescribe walking with confidence that it will evoke health benefit. As in our previous meta-analysis, few studies have investigated the effects of walking interventions on non-traditional cardiovascular disease risk factors, such as markers of inflammation, oxidative stress and coagulation (Murphy et al., 2007) . Future research should incorporate these measures and further examine the effect of walking in specific populations including ethnic minorities and older adults. The results and recommendations of this meta-analysis are of relevance for health professionals involved in the primary prevention of cardiovascular disease and should underscore the central role of walking as a cornerstone in physical activity for health promotion.
Figure 1: Study selection process
Databases were searched for articles published between Jan 1971 and June 2012.
